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Pharmaceuticals and their residues in the environment have been recently recognized as 
one of the emerging research areas in the environmental chemistry and toxicology and 
caused them to be viewed as a new class of priority substances. It has been reported 
that they are introduced continuously in the environment via household use, effluents 
from Sewage Treatment Plants (STPs) and animal excreta. Up to date, the potential 
human, animal and ecological risk associated with the occurrence of these compounds 
in the environment is not well documented. There is an increased attention due to the 
fact that they are designed to have specific effects at low doses and to be resistant to 
metabolic degradation. There is also the potential to create antibiotic resistance. 
Moreover, the science of mixture toxicity is complex and to date quite unknown (Bound 
et al., 2006; Hernando et al., 2006).  
Despite the increased research and regulatory interest in the occurrence of 
pharmaceuticals and their degradation products in STPs effluents and freshwater 
ecosystems (Hernando et al., 2006), the occurrence, the distribution between the 
different environmental compartments (i.e. water, sediments, suspended solids and 
aqueous organisms), the trophic transfer and their potential toxicity is to date far less 
documented (Emblidge and DeLorenze, 2006).  
In this sense, this study will present a detection method for the determination of a large 
group of pharmaceuticals (i.e. antibiotics, beta-agonists, painkillers, tranquilizers, non-
steroidal anti-inflammatory drugs) used both in human and veterinary practice in 
environmental samples using Liquid Chromatography coupled to multiple Mass 
Spectrometry. 
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